Tremelimumab(Imjudo),precautions-Seagull Pharmacy

IMJUDO (tremelimumab-actl) is indicated, in combination with durvalumab, for the treatment of adult patients with unresectable hepatocellular carcinoma (uHCC).

CATEGORY NAVIGATION

Tremelimumab Indications
Tremelimumab Dosage
Tremelimumab Prices
Tremelimumab Treatment Effects
Tremelimumab Precautions
Tremelimumab Side Effects

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

Mailbox:Info@Lucius.La

Welcome To Consult